학술논문
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India
Document Type
Article
Author
Kulkarni, Prasad S; Padmapriyadarsini, Chandrasekaran; Vekemans, Johan; Bavdekar, Ashish; Gupta, Madhu; Kulkarni, Praveen; Garg, B S; Gogtay, Nithya J; Tambe, Muralidhar; Lalwani, Sanjay; Singh, Kiranjit; Munshi, Renuka; Meshram, Sushant; Selvavinayagam, T S; Pandey, Krishna; Bhimarasetty, Devi Madhavi; Ramakrishnan, S R; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Vadakkedath, Rajeev; Bonhomme, Cyrille J; Thakar, Madhuri; Kurle, Swarali N; Kelly, Elizabeth J; Gautam, Manish; Gupta, Nivedita; Panda, Samiran; Bhargava, Balram; Shaligram, Umesh; Kapse, Dhananjay; Gunale, Bhagwat
Source
In eClinicalMedicine December 2021 42
Subject
Language
ISSN
2589-5370